CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 31 filers reported holding CYTEIR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,097 | +96.7% | 34,189 | +80.1% | 0.00% | – |
| Q2 2023 | $49,358 | +42.9% | 18,984 | 0.0% | 0.00% | – |
| Q1 2023 | $34,551 | +40.5% | 18,984 | +27.3% | 0.00% | – |
| Q4 2022 | $24,597 | -1.6% | 14,907 | +13.1% | 0.00% | – |
| Q3 2022 | $25,000 | -35.9% | 13,175 | 0.0% | 0.00% | – |
| Q2 2022 | $39,000 | -92.5% | 13,175 | -90.5% | 0.00% | – |
| Q1 2022 | $521,000 | -36.7% | 138,244 | +90.9% | 0.00% | – |
| Q4 2021 | $823,000 | -35.9% | 72,425 | -1.0% | 0.00% | – |
| Q3 2021 | $1,284,000 | – | 73,183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,459,572 | $6,985,184 | 15.71% |
| BML Capital Management, LLC | 3,250,008 | $9,230,023 | 8.48% |
| Newtyn Management, LLC | 2,500,444 | $7,101,261 | 1.75% |
| VR Advisory Services Ltd | 1,072,968 | $3,047,229 | 1.08% |
| Anson Funds Management LP | 1,324,114 | $3,760,484 | 0.76% |
| Acuitas Investments, LLC | 329,164 | $934,826 | 0.55% |
| Aldebaran Capital, LLC | 143,739 | $408,219 | 0.42% |
| Bulldog Investors, LLP | 200,000 | $568,000 | 0.20% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 416,200 | $1,182,008 | 0.19% |
| Alta Fundamental Advisers LLC | 117,346 | $333,263 | 0.16% |